Current and future options for Fuchs endothelial corneal dystrophy
Kathryn A. Colby, MD, PhD
Advertisement
Articles by Kathryn A. Colby, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Ophthalmology Times Europe
1
FLORetina: Inadvertent anti-VEGF interval increases during the COVID-19 pandemic
2
Dompé enrolls first patients in phase 3 trial of Isocyclosporin for atopic keratoconjunctivitis
3
FLORetina 2025: AI in practice, discussed by Marion Munk and Quan Dong Nguyen
4